Exclusive

Publication

Byline

First PMDA-approved molecular residual disease (MRD) test enters Japan

Singapore, June 24 -- US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has received regulatory approval from Japan's Pharmaceuticals and Med... Read More


Abu Dhabi, Biocom California form life sciences corridor

Singapore, June 24 -- The Department of Health - Abu Dhabi and Biocom California have announced a strategic partnership to create a formal gateway between Abu Dhabi and California's life sciences ecos... Read More


China's Abbisko deepens R&D collaboration with Eli Lilly for novel drug programmes

Singapore, June 24 -- China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based Eli Lilly and Company to discover and develop innovative ... Read More


SystImmune, Biokin Secure First China Approval for Bispecific ADC Iza-bren

Singapore, June 23 -- SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, also known as BL-B01D1, for the treatment of recurrent or met... Read More


Sankara Eye Hospital and Chinese University of Hong Kong ink MoU to revolutionise paediatric eye care and myopia treatment

Singapore, June 23 -- Sankara Eye Hospital, India and The Chinese University of Hong Kong (CUHK) recently signed a landmark Memorandum of Understanding (MoU) to revolutionise paediatric eye care and m... Read More


Sisram Medical bolsters Energy-Based Devices and injectables in Thailand

Singapore, June 23 -- Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, has officially rolled out its Soprano Titanium across... Read More


Abu Dhabi's government partners with Sanofi to advance vaccine innovation

Singapore, June 23 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum ... Read More


China's CARsgen announces approval of Satri-cel, world's first CAR T-cell therapy product for solid tumours

Singapore, June 23 -- China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as informed by the National Medical Products Administration ... Read More


Sartorius strengthens collaboration with LFB Biomanufacturing

Singapore, June 23 -- Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biopharmaceutical clients a comprehensive cell-line development (CL... Read More


Murj(R) expands global footprint with commercial launch in Australia and NZ

Singapore, June 22 -- Murj(R), a US-based cardiac device management software company, has announced its official expansion into the Australian market alongside broader availability for New Zealand (NZ... Read More